Hindustan Bio Sciences Reports Q1 Results, Appoints New Company Secretary
Hindustan Bio Sciences Ltd. reported Q1 FY2026 financial results with revenue from operations at Rs. 32.19 lakhs, down from previous periods but maintaining profitability at Rs. 1.40 lakhs. The company announced management changes with Mr. Devanshu Ravinder Dange resigning as Company Secretary and Mr. Shailendra Vyas appointed as the new Company Secretary, effective August 1. The board also approved various corporate governance matters including the notice for the 33rd AGM and adoption of the Secretarial Audit Report.
*this image is generated using AI for illustrative purposes only.
Hindustan Bio Sciences Ltd. has announced its financial results for the first quarter, along with key management changes. The company's board meeting, held on July 31, addressed several important matters, including financial performance and corporate governance.
Q1 Financial Performance
For the quarter ended June 30, Hindustan Bio Sciences reported:
| Particulars | Q1 FY2026 (Rs. in lakhs) | Q4 FY2025 (Rs. in lakhs) | Q1 FY2025 (Rs. in lakhs) |
|---|---|---|---|
| Revenue from operations | 32.19 | 37.53 | 41.11 |
| Total Revenue | 33.50 | 38.79 | 42.54 |
| Total Expenses | 32.11 | 28.00 | 34.36 |
| Profit before tax | 1.40 | 10.79 | 8.18 |
| Profit for the period | 1.40 | 10.79 | 8.18 |
The company's revenue from operations for Q1 FY2026 stood at Rs. 32.19 lakhs, showing a decrease compared to both the previous quarter and the same quarter last year. Despite the revenue decline, Hindustan Bio Sciences managed to maintain profitability, reporting a profit of Rs. 1.40 lakhs for the quarter.
Management Changes
In a significant development, the company announced changes in its key managerial personnel:
Resignation of Company Secretary: Mr. Devanshu Ravinder Dange has resigned from his position as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective from the closing business hours of July 31. Mr. Dange cited personal reasons for his departure.
New Appointment: Mr. Shailendra Vyas has been appointed as the new Company Secretary, Key Managerial Personnel, and Compliance Officer, effective August 1. Mr. Vyas is an Associate Member of the Institute of Company Secretaries of India (ICSI) and holds a Bachelor's degree in Commerce (Computer Applications) from Telangana University and a Bachelor's degree in Law (LL.B.) from Osmania University.
Corporate Governance and Compliance
The board meeting also addressed several corporate governance matters:
- Approval of the notice for the 33rd Annual General Meeting (AGM), along with the Directors' report and Corporate Governance report for the financial year ended March 31.
- Adoption of the Secretarial Audit Report for the Financial Year 2024-25, issued by Mr. VBSS Prasad, Practicing Company Secretary.
- Appointment of Mr. VBSS Prasad as the scrutinizer for conducting e-voting at the upcoming AGM.
Looking Ahead
While the company faced a decline in revenue compared to previous periods, it has maintained profitability. The management changes and focus on corporate governance indicate Hindustan Bio Sciences' commitment to strengthening its organizational structure and compliance practices.
Investors and stakeholders will be keenly watching how these changes and the company's strategies impact its performance in the coming quarters.
Historical Stock Returns for Hindustan Bio Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -9.52% | -22.97% | -41.54% | -46.23% | -31.90% |
20
